Medical Care
Global Guide RNA Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 04, 25
- ID: 531719
- Pages: 138
- Figures: 140
- Views: 34
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Guide RNA market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Thermo Fisher Scientific
Agilent Technologies
System Biosciences
Jena Bioscience GmbH
Merck KGaA
Azenta
Takara Bio
Synbio Technologies
Revvity
Synthego Corporation
GenScript Biotech Corporation
Omicsbio
SBS Genetech
Segment by Type
sgRNA
Guide RNA in RNA Editing
Others
Segment by Application
Bioengineering
Medicine
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Guide RNA study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Guide RNA market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Thermo Fisher Scientific
Agilent Technologies
System Biosciences
Jena Bioscience GmbH
Merck KGaA
Azenta
Takara Bio
Synbio Technologies
Revvity
Synthego Corporation
GenScript Biotech Corporation
Omicsbio
SBS Genetech
Segment by Type
sgRNA
Guide RNA in RNA Editing
Others
Segment by Application
Bioengineering
Medicine
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Guide RNA study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Guide RNA: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Guide RNA Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 sgRNA
1.2.3 Guide RNA in RNA Editing
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Guide RNA Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Bioengineering
1.3.3 Medicine
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Guide RNA Revenue Estimates and Forecasts 2020-2031
2.2 Global Guide RNA Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Guide RNA Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Guide RNA Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 sgRNA Market Size by Players
3.3.2 Guide RNA in RNA Editing Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Guide RNA Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Guide RNA Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Guide RNA Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Guide RNA Market Size by Type (2020-2031)
6.4 North America Guide RNA Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Guide RNA Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Guide RNA Market Size by Type (2020-2031)
7.4 Europe Guide RNA Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Guide RNA Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Guide RNA Market Size by Type (2020-2031)
8.4 Asia-Pacific Guide RNA Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Guide RNA Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Guide RNA Market Size by Type (2020-2031)
9.4 Central and South America Guide RNA Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Guide RNA Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Guide RNA Market Size by Type (2020-2031)
10.4 Middle East and Africa Guide RNA Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Guide RNA Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Guide RNA Product Features and Attributes
11.1.4 Thermo Fisher Scientific Guide RNA Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Guide RNA Revenue by Product in 2024
11.1.6 Thermo Fisher Scientific Guide RNA Revenue by Application in 2024
11.1.7 Thermo Fisher Scientific Guide RNA Revenue by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Guide RNA SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Corporation Information
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Guide RNA Product Features and Attributes
11.2.4 Agilent Technologies Guide RNA Revenue and Gross Margin (2020-2025)
11.2.5 Agilent Technologies Guide RNA Revenue by Product in 2024
11.2.6 Agilent Technologies Guide RNA Revenue by Application in 2024
11.2.7 Agilent Technologies Guide RNA Revenue by Geographic Area in 2024
11.2.8 Agilent Technologies Guide RNA SWOT Analysis
11.2.9 Agilent Technologies Recent Developments
11.3 System Biosciences
11.3.1 System Biosciences Corporation Information
11.3.2 System Biosciences Business Overview
11.3.3 System Biosciences Guide RNA Product Features and Attributes
11.3.4 System Biosciences Guide RNA Revenue and Gross Margin (2020-2025)
11.3.5 System Biosciences Guide RNA Revenue by Product in 2024
11.3.6 System Biosciences Guide RNA Revenue by Application in 2024
11.3.7 System Biosciences Guide RNA Revenue by Geographic Area in 2024
11.3.8 System Biosciences Guide RNA SWOT Analysis
11.3.9 System Biosciences Recent Developments
11.4 Jena Bioscience GmbH
11.4.1 Jena Bioscience GmbH Corporation Information
11.4.2 Jena Bioscience GmbH Business Overview
11.4.3 Jena Bioscience GmbH Guide RNA Product Features and Attributes
11.4.4 Jena Bioscience GmbH Guide RNA Revenue and Gross Margin (2020-2025)
11.4.5 Jena Bioscience GmbH Guide RNA Revenue by Product in 2024
11.4.6 Jena Bioscience GmbH Guide RNA Revenue by Application in 2024
11.4.7 Jena Bioscience GmbH Guide RNA Revenue by Geographic Area in 2024
11.4.8 Jena Bioscience GmbH Guide RNA SWOT Analysis
11.4.9 Jena Bioscience GmbH Recent Developments
11.5 Merck KGaA
11.5.1 Merck KGaA Corporation Information
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Guide RNA Product Features and Attributes
11.5.4 Merck KGaA Guide RNA Revenue and Gross Margin (2020-2025)
11.5.5 Merck KGaA Guide RNA Revenue by Product in 2024
11.5.6 Merck KGaA Guide RNA Revenue by Application in 2024
11.5.7 Merck KGaA Guide RNA Revenue by Geographic Area in 2024
11.5.8 Merck KGaA Guide RNA SWOT Analysis
11.5.9 Merck KGaA Recent Developments
11.6 Azenta
11.6.1 Azenta Corporation Information
11.6.2 Azenta Business Overview
11.6.3 Azenta Guide RNA Product Features and Attributes
11.6.4 Azenta Guide RNA Revenue and Gross Margin (2020-2025)
11.6.5 Azenta Recent Developments
11.7 Takara Bio
11.7.1 Takara Bio Corporation Information
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Guide RNA Product Features and Attributes
11.7.4 Takara Bio Guide RNA Revenue and Gross Margin (2020-2025)
11.7.5 Takara Bio Recent Developments
11.8 Synbio Technologies
11.8.1 Synbio Technologies Corporation Information
11.8.2 Synbio Technologies Business Overview
11.8.3 Synbio Technologies Guide RNA Product Features and Attributes
11.8.4 Synbio Technologies Guide RNA Revenue and Gross Margin (2020-2025)
11.8.5 Synbio Technologies Recent Developments
11.9 Revvity
11.9.1 Revvity Corporation Information
11.9.2 Revvity Business Overview
11.9.3 Revvity Guide RNA Product Features and Attributes
11.9.4 Revvity Guide RNA Revenue and Gross Margin (2020-2025)
11.9.5 Revvity Recent Developments
11.10 Synthego Corporation
11.10.1 Synthego Corporation Corporation Information
11.10.2 Synthego Corporation Business Overview
11.10.3 Synthego Corporation Guide RNA Product Features and Attributes
11.10.4 Synthego Corporation Guide RNA Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 GenScript Biotech Corporation
11.11.1 GenScript Biotech Corporation Corporation Information
11.11.2 GenScript Biotech Corporation Business Overview
11.11.3 GenScript Biotech Corporation Guide RNA Product Features and Attributes
11.11.4 GenScript Biotech Corporation Guide RNA Revenue and Gross Margin (2020-2025)
11.11.5 GenScript Biotech Corporation Recent Developments
11.12 Omicsbio
11.12.1 Omicsbio Corporation Information
11.12.2 Omicsbio Business Overview
11.12.3 Omicsbio Guide RNA Product Features and Attributes
11.12.4 Omicsbio Guide RNA Revenue and Gross Margin (2020-2025)
11.12.5 Omicsbio Recent Developments
11.13 SBS Genetech
11.13.1 SBS Genetech Corporation Information
11.13.2 SBS Genetech Business Overview
11.13.3 SBS Genetech Guide RNA Product Features and Attributes
11.13.4 SBS Genetech Guide RNA Revenue and Gross Margin (2020-2025)
11.13.5 SBS Genetech Recent Developments
12 Guide RNAIndustry Chain Analysis
12.1 Guide RNA Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Guide RNA Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Guide RNA Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Guide RNA: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Guide RNA Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 sgRNA
1.2.3 Guide RNA in RNA Editing
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Guide RNA Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Bioengineering
1.3.3 Medicine
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Guide RNA Revenue Estimates and Forecasts 2020-2031
2.2 Global Guide RNA Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Guide RNA Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Guide RNA Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 sgRNA Market Size by Players
3.3.2 Guide RNA in RNA Editing Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Guide RNA Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Guide RNA Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Guide RNA Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Guide RNA Market Size by Type (2020-2031)
6.4 North America Guide RNA Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Guide RNA Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Guide RNA Market Size by Type (2020-2031)
7.4 Europe Guide RNA Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Guide RNA Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Guide RNA Market Size by Type (2020-2031)
8.4 Asia-Pacific Guide RNA Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Guide RNA Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Guide RNA Market Size by Type (2020-2031)
9.4 Central and South America Guide RNA Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Guide RNA Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Guide RNA Market Size by Type (2020-2031)
10.4 Middle East and Africa Guide RNA Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Guide RNA Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Guide RNA Product Features and Attributes
11.1.4 Thermo Fisher Scientific Guide RNA Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Guide RNA Revenue by Product in 2024
11.1.6 Thermo Fisher Scientific Guide RNA Revenue by Application in 2024
11.1.7 Thermo Fisher Scientific Guide RNA Revenue by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Guide RNA SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Corporation Information
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Guide RNA Product Features and Attributes
11.2.4 Agilent Technologies Guide RNA Revenue and Gross Margin (2020-2025)
11.2.5 Agilent Technologies Guide RNA Revenue by Product in 2024
11.2.6 Agilent Technologies Guide RNA Revenue by Application in 2024
11.2.7 Agilent Technologies Guide RNA Revenue by Geographic Area in 2024
11.2.8 Agilent Technologies Guide RNA SWOT Analysis
11.2.9 Agilent Technologies Recent Developments
11.3 System Biosciences
11.3.1 System Biosciences Corporation Information
11.3.2 System Biosciences Business Overview
11.3.3 System Biosciences Guide RNA Product Features and Attributes
11.3.4 System Biosciences Guide RNA Revenue and Gross Margin (2020-2025)
11.3.5 System Biosciences Guide RNA Revenue by Product in 2024
11.3.6 System Biosciences Guide RNA Revenue by Application in 2024
11.3.7 System Biosciences Guide RNA Revenue by Geographic Area in 2024
11.3.8 System Biosciences Guide RNA SWOT Analysis
11.3.9 System Biosciences Recent Developments
11.4 Jena Bioscience GmbH
11.4.1 Jena Bioscience GmbH Corporation Information
11.4.2 Jena Bioscience GmbH Business Overview
11.4.3 Jena Bioscience GmbH Guide RNA Product Features and Attributes
11.4.4 Jena Bioscience GmbH Guide RNA Revenue and Gross Margin (2020-2025)
11.4.5 Jena Bioscience GmbH Guide RNA Revenue by Product in 2024
11.4.6 Jena Bioscience GmbH Guide RNA Revenue by Application in 2024
11.4.7 Jena Bioscience GmbH Guide RNA Revenue by Geographic Area in 2024
11.4.8 Jena Bioscience GmbH Guide RNA SWOT Analysis
11.4.9 Jena Bioscience GmbH Recent Developments
11.5 Merck KGaA
11.5.1 Merck KGaA Corporation Information
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Guide RNA Product Features and Attributes
11.5.4 Merck KGaA Guide RNA Revenue and Gross Margin (2020-2025)
11.5.5 Merck KGaA Guide RNA Revenue by Product in 2024
11.5.6 Merck KGaA Guide RNA Revenue by Application in 2024
11.5.7 Merck KGaA Guide RNA Revenue by Geographic Area in 2024
11.5.8 Merck KGaA Guide RNA SWOT Analysis
11.5.9 Merck KGaA Recent Developments
11.6 Azenta
11.6.1 Azenta Corporation Information
11.6.2 Azenta Business Overview
11.6.3 Azenta Guide RNA Product Features and Attributes
11.6.4 Azenta Guide RNA Revenue and Gross Margin (2020-2025)
11.6.5 Azenta Recent Developments
11.7 Takara Bio
11.7.1 Takara Bio Corporation Information
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Guide RNA Product Features and Attributes
11.7.4 Takara Bio Guide RNA Revenue and Gross Margin (2020-2025)
11.7.5 Takara Bio Recent Developments
11.8 Synbio Technologies
11.8.1 Synbio Technologies Corporation Information
11.8.2 Synbio Technologies Business Overview
11.8.3 Synbio Technologies Guide RNA Product Features and Attributes
11.8.4 Synbio Technologies Guide RNA Revenue and Gross Margin (2020-2025)
11.8.5 Synbio Technologies Recent Developments
11.9 Revvity
11.9.1 Revvity Corporation Information
11.9.2 Revvity Business Overview
11.9.3 Revvity Guide RNA Product Features and Attributes
11.9.4 Revvity Guide RNA Revenue and Gross Margin (2020-2025)
11.9.5 Revvity Recent Developments
11.10 Synthego Corporation
11.10.1 Synthego Corporation Corporation Information
11.10.2 Synthego Corporation Business Overview
11.10.3 Synthego Corporation Guide RNA Product Features and Attributes
11.10.4 Synthego Corporation Guide RNA Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 GenScript Biotech Corporation
11.11.1 GenScript Biotech Corporation Corporation Information
11.11.2 GenScript Biotech Corporation Business Overview
11.11.3 GenScript Biotech Corporation Guide RNA Product Features and Attributes
11.11.4 GenScript Biotech Corporation Guide RNA Revenue and Gross Margin (2020-2025)
11.11.5 GenScript Biotech Corporation Recent Developments
11.12 Omicsbio
11.12.1 Omicsbio Corporation Information
11.12.2 Omicsbio Business Overview
11.12.3 Omicsbio Guide RNA Product Features and Attributes
11.12.4 Omicsbio Guide RNA Revenue and Gross Margin (2020-2025)
11.12.5 Omicsbio Recent Developments
11.13 SBS Genetech
11.13.1 SBS Genetech Corporation Information
11.13.2 SBS Genetech Business Overview
11.13.3 SBS Genetech Guide RNA Product Features and Attributes
11.13.4 SBS Genetech Guide RNA Revenue and Gross Margin (2020-2025)
11.13.5 SBS Genetech Recent Developments
12 Guide RNAIndustry Chain Analysis
12.1 Guide RNA Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Guide RNA Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Guide RNA Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Guide RNA Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Guide RNA Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Guide RNA Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Guide RNA Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Guide RNA Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Guide RNA Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Guide RNA Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Guide RNA by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guide RNA as of 2024)
Table 11. Global Guide RNA Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Guide RNA Companies Headquarters
Table 13. Global Guide RNA Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Guide RNA Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Guide RNA Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Guide RNA Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Guide RNA Revenue by Application (2026-2031) & (US$ Million)
Table 21. Guide RNA High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Guide RNA Growth Accelerators and Market Barriers
Table 25. North America Guide RNA Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Guide RNA Growth Accelerators and Market Barriers
Table 27. Europe Guide RNA Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Guide RNA Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Guide RNA Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Guide RNA Investment Opportunities and Key Challenges
Table 31. Central and South America Guide RNA Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Guide RNA Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Guide RNA Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Thermo Fisher Scientific Corporation Information
Table 35. Thermo Fisher Scientific Description and Major Businesses
Table 36. Thermo Fisher Scientific Product Features and Attributes
Table 37. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 39. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 40. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 41. Thermo Fisher Scientific Guide RNA SWOT Analysis
Table 42. Thermo Fisher Scientific Recent Developments
Table 43. Agilent Technologies Corporation Information
Table 44. Agilent Technologies Description and Major Businesses
Table 45. Agilent Technologies Product Features and Attributes
Table 46. Agilent Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Agilent Technologies Revenue Proportion by Product in 2024
Table 48. Agilent Technologies Revenue Proportion by Application in 2024
Table 49. Agilent Technologies Revenue Proportion by Geographic Area in 2024
Table 50. Agilent Technologies Guide RNA SWOT Analysis
Table 51. Agilent Technologies Recent Developments
Table 52. System Biosciences Corporation Information
Table 53. System Biosciences Description and Major Businesses
Table 54. System Biosciences Product Features and Attributes
Table 55. System Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. System Biosciences Revenue Proportion by Product in 2024
Table 57. System Biosciences Revenue Proportion by Application in 2024
Table 58. System Biosciences Revenue Proportion by Geographic Area in 2024
Table 59. System Biosciences Guide RNA SWOT Analysis
Table 60. System Biosciences Recent Developments
Table 61. Jena Bioscience GmbH Corporation Information
Table 62. Jena Bioscience GmbH Description and Major Businesses
Table 63. Jena Bioscience GmbH Product Features and Attributes
Table 64. Jena Bioscience GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Jena Bioscience GmbH Revenue Proportion by Product in 2024
Table 66. Jena Bioscience GmbH Revenue Proportion by Application in 2024
Table 67. Jena Bioscience GmbH Revenue Proportion by Geographic Area in 2024
Table 68. Jena Bioscience GmbH Guide RNA SWOT Analysis
Table 69. Jena Bioscience GmbH Recent Developments
Table 70. Merck KGaA Corporation Information
Table 71. Merck KGaA Description and Major Businesses
Table 72. Merck KGaA Product Features and Attributes
Table 73. Merck KGaA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Merck KGaA Revenue Proportion by Product in 2024
Table 75. Merck KGaA Revenue Proportion by Application in 2024
Table 76. Merck KGaA Revenue Proportion by Geographic Area in 2024
Table 77. Merck KGaA Guide RNA SWOT Analysis
Table 78. Merck KGaA Recent Developments
Table 79. Azenta Corporation Information
Table 80. Azenta Description and Major Businesses
Table 81. Azenta Product Features and Attributes
Table 82. Azenta Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Azenta Recent Developments
Table 84. Takara Bio Corporation Information
Table 85. Takara Bio Description and Major Businesses
Table 86. Takara Bio Product Features and Attributes
Table 87. Takara Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Takara Bio Recent Developments
Table 89. Synbio Technologies Corporation Information
Table 90. Synbio Technologies Description and Major Businesses
Table 91. Synbio Technologies Product Features and Attributes
Table 92. Synbio Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Synbio Technologies Recent Developments
Table 94. Revvity Corporation Information
Table 95. Revvity Description and Major Businesses
Table 96. Revvity Product Features and Attributes
Table 97. Revvity Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Revvity Recent Developments
Table 99. Synthego Corporation Corporation Information
Table 100. Synthego Corporation Description and Major Businesses
Table 101. Synthego Corporation Product Features and Attributes
Table 102. Synthego Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Synthego Corporation Recent Developments
Table 104. GenScript Biotech Corporation Corporation Information
Table 105. GenScript Biotech Corporation Description and Major Businesses
Table 106. GenScript Biotech Corporation Product Features and Attributes
Table 107. GenScript Biotech Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. GenScript Biotech Corporation Recent Developments
Table 109. Omicsbio Corporation Information
Table 110. Omicsbio Description and Major Businesses
Table 111. Omicsbio Product Features and Attributes
Table 112. Omicsbio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Omicsbio Recent Developments
Table 114. SBS Genetech Corporation Information
Table 115. SBS Genetech Description and Major Businesses
Table 116. SBS Genetech Product Features and Attributes
Table 117. SBS Genetech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. SBS Genetech Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Guide RNA Product Picture
Figure 2. Global Guide RNA Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. sgRNA Product Picture
Figure 4. Guide RNA in RNA Editing Product Picture
Figure 5. Others Product Picture
Figure 6. Global Guide RNA Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Bioengineering
Figure 8. Medicine
Figure 9. Others
Figure 10. Guide RNA Report Years Considered
Figure 11. Global Guide RNA Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 13. Global Guide RNA Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Guide RNA Revenue Market Share by Region (2020-2031)
Figure 15. Global Guide RNA Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. sgRNA Revenue Market Share by Player in 2024
Figure 18. Guide RNA in RNA Editing Revenue Market Share by Player in 2024
Figure 19. Others Revenue Market Share by Player in 2024
Figure 20. Global Guide RNA Revenue Market Share by Type (2020-2031)
Figure 21. Global Guide RNA Revenue Market Share by Application (2020-2031)
Figure 22. North America Guide RNA Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Guide RNA Revenue (US$ Million) in 2024
Figure 24. North America Guide RNA Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Guide RNA Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Guide RNA Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Guide RNA Revenue (US$ Million) in 2024
Figure 31. Europe Guide RNA Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Guide RNA Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 34. France Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Guide RNA Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Guide RNA Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Guide RNA Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Guide RNA Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 46. India Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Guide RNA Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Guide RNA Revenue (US$ Million) in 2024
Figure 54. Central and South America Guide RNA Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Guide RNA Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Guide RNA Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Guide RNA Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Guide RNA Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Guide RNA Revenue (US$ Million) in 2024
Figure 60. South America Guide RNA Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Guide RNA Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Guide RNA Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Guide RNA Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Guide RNA Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Guide RNA Revenue (2020-2025) & (US$ Million)
Figure 66. Guide RNA Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Guide RNA Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Guide RNA Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Guide RNA Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Guide RNA Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Guide RNA Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Guide RNA Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Guide RNA Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Guide RNA by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guide RNA as of 2024)
Table 11. Global Guide RNA Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Guide RNA Companies Headquarters
Table 13. Global Guide RNA Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Guide RNA Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Guide RNA Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Guide RNA Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Guide RNA Revenue by Application (2026-2031) & (US$ Million)
Table 21. Guide RNA High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Guide RNA Growth Accelerators and Market Barriers
Table 25. North America Guide RNA Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Guide RNA Growth Accelerators and Market Barriers
Table 27. Europe Guide RNA Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Guide RNA Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Guide RNA Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Guide RNA Investment Opportunities and Key Challenges
Table 31. Central and South America Guide RNA Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Guide RNA Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Guide RNA Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Thermo Fisher Scientific Corporation Information
Table 35. Thermo Fisher Scientific Description and Major Businesses
Table 36. Thermo Fisher Scientific Product Features and Attributes
Table 37. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 39. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 40. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 41. Thermo Fisher Scientific Guide RNA SWOT Analysis
Table 42. Thermo Fisher Scientific Recent Developments
Table 43. Agilent Technologies Corporation Information
Table 44. Agilent Technologies Description and Major Businesses
Table 45. Agilent Technologies Product Features and Attributes
Table 46. Agilent Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Agilent Technologies Revenue Proportion by Product in 2024
Table 48. Agilent Technologies Revenue Proportion by Application in 2024
Table 49. Agilent Technologies Revenue Proportion by Geographic Area in 2024
Table 50. Agilent Technologies Guide RNA SWOT Analysis
Table 51. Agilent Technologies Recent Developments
Table 52. System Biosciences Corporation Information
Table 53. System Biosciences Description and Major Businesses
Table 54. System Biosciences Product Features and Attributes
Table 55. System Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. System Biosciences Revenue Proportion by Product in 2024
Table 57. System Biosciences Revenue Proportion by Application in 2024
Table 58. System Biosciences Revenue Proportion by Geographic Area in 2024
Table 59. System Biosciences Guide RNA SWOT Analysis
Table 60. System Biosciences Recent Developments
Table 61. Jena Bioscience GmbH Corporation Information
Table 62. Jena Bioscience GmbH Description and Major Businesses
Table 63. Jena Bioscience GmbH Product Features and Attributes
Table 64. Jena Bioscience GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Jena Bioscience GmbH Revenue Proportion by Product in 2024
Table 66. Jena Bioscience GmbH Revenue Proportion by Application in 2024
Table 67. Jena Bioscience GmbH Revenue Proportion by Geographic Area in 2024
Table 68. Jena Bioscience GmbH Guide RNA SWOT Analysis
Table 69. Jena Bioscience GmbH Recent Developments
Table 70. Merck KGaA Corporation Information
Table 71. Merck KGaA Description and Major Businesses
Table 72. Merck KGaA Product Features and Attributes
Table 73. Merck KGaA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Merck KGaA Revenue Proportion by Product in 2024
Table 75. Merck KGaA Revenue Proportion by Application in 2024
Table 76. Merck KGaA Revenue Proportion by Geographic Area in 2024
Table 77. Merck KGaA Guide RNA SWOT Analysis
Table 78. Merck KGaA Recent Developments
Table 79. Azenta Corporation Information
Table 80. Azenta Description and Major Businesses
Table 81. Azenta Product Features and Attributes
Table 82. Azenta Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Azenta Recent Developments
Table 84. Takara Bio Corporation Information
Table 85. Takara Bio Description and Major Businesses
Table 86. Takara Bio Product Features and Attributes
Table 87. Takara Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Takara Bio Recent Developments
Table 89. Synbio Technologies Corporation Information
Table 90. Synbio Technologies Description and Major Businesses
Table 91. Synbio Technologies Product Features and Attributes
Table 92. Synbio Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Synbio Technologies Recent Developments
Table 94. Revvity Corporation Information
Table 95. Revvity Description and Major Businesses
Table 96. Revvity Product Features and Attributes
Table 97. Revvity Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Revvity Recent Developments
Table 99. Synthego Corporation Corporation Information
Table 100. Synthego Corporation Description and Major Businesses
Table 101. Synthego Corporation Product Features and Attributes
Table 102. Synthego Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Synthego Corporation Recent Developments
Table 104. GenScript Biotech Corporation Corporation Information
Table 105. GenScript Biotech Corporation Description and Major Businesses
Table 106. GenScript Biotech Corporation Product Features and Attributes
Table 107. GenScript Biotech Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. GenScript Biotech Corporation Recent Developments
Table 109. Omicsbio Corporation Information
Table 110. Omicsbio Description and Major Businesses
Table 111. Omicsbio Product Features and Attributes
Table 112. Omicsbio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Omicsbio Recent Developments
Table 114. SBS Genetech Corporation Information
Table 115. SBS Genetech Description and Major Businesses
Table 116. SBS Genetech Product Features and Attributes
Table 117. SBS Genetech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. SBS Genetech Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Guide RNA Product Picture
Figure 2. Global Guide RNA Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. sgRNA Product Picture
Figure 4. Guide RNA in RNA Editing Product Picture
Figure 5. Others Product Picture
Figure 6. Global Guide RNA Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Bioengineering
Figure 8. Medicine
Figure 9. Others
Figure 10. Guide RNA Report Years Considered
Figure 11. Global Guide RNA Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 13. Global Guide RNA Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Guide RNA Revenue Market Share by Region (2020-2031)
Figure 15. Global Guide RNA Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. sgRNA Revenue Market Share by Player in 2024
Figure 18. Guide RNA in RNA Editing Revenue Market Share by Player in 2024
Figure 19. Others Revenue Market Share by Player in 2024
Figure 20. Global Guide RNA Revenue Market Share by Type (2020-2031)
Figure 21. Global Guide RNA Revenue Market Share by Application (2020-2031)
Figure 22. North America Guide RNA Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Guide RNA Revenue (US$ Million) in 2024
Figure 24. North America Guide RNA Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Guide RNA Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Guide RNA Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Guide RNA Revenue (US$ Million) in 2024
Figure 31. Europe Guide RNA Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Guide RNA Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 34. France Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Guide RNA Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Guide RNA Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Guide RNA Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Guide RNA Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 46. India Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Guide RNA Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Guide RNA Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Guide RNA Revenue (US$ Million) in 2024
Figure 54. Central and South America Guide RNA Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Guide RNA Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Guide RNA Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Guide RNA Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Guide RNA Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Guide RNA Revenue (US$ Million) in 2024
Figure 60. South America Guide RNA Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Guide RNA Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Guide RNA Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Guide RNA Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Guide RNA Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Guide RNA Revenue (2020-2025) & (US$ Million)
Figure 66. Guide RNA Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232